# Westlake Chemical Partners LP (WLKP) · Edgar & Edgarette company card

> Westlake Chemical Partners (WLKP) grew revenue 2.7% in FY2025 to $1.2 billion, operating margin 27.4% against a -3.2% median for industrial organic chemicals. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1604665 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/WLKP) · [JSON](https://www.pops4.com/boards/company/WLKP.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $1.2B |
| Revenue growth, 1 year | 2.7% |
| Revenue growth per year | -1.0% |
| Operating margin | 27.4% (prior year 34.4%) |
| Net margin | 25.6% |
| Operating cash flow | $280M |
| Capital spending | $79M |
| Free cash flow | $202M |
| Cash | $44M |
| Long-term debt | — |
| Total assets | $1.3B |
| Total equity | — |
| Equity ÷ assets | — |
| Return on equity | — |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Piotroski F: 4 of 9 (middling)
- Beneish M: -2.22 (below the −1.78 line)
- Health Harbor boat: Weathered boat · two warning signs · slow and jumpy: growing slower than its size class, with revenue that swings more; revenue is hard to predict: its 80% range is ±26%
- Cash Compass: Fading · slow and jumpy, lagging its peers

## Edgarette's reading

Exposure: revenue $1.2B (FY2025). Experience: revenue up 2.7% on the year, down 1.0% a year over 4 years; operating margin 27.4%, down from 34.4%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $845.0M and $1.4B next year (method v4.1: its own 4-year record of growth weighed at 50% against $1B–10B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $697.3M to $1.7B. A statistical range, not company guidance. Against peers (13 filers, $50M+ revenue, industrial organic chemicals): operating margin 27.4% against a -3.2% median; growth 2.7% against -3.5%.

Range logged 2026-10-31, receipt 1f0f2f50549d3a38, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 3, latest 2026-08-31 ([filing](https://www.sec.gov/Archives/edgar/data/1604665/000119312526377003/0001193125-26-377003-index.htm))

## Recent filings

- 8-K · filed 2026-08-31 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/1604665/000119312526377003/0001193125-26-377003-index.htm)
- 10-Q · filed 2026-08-05 · [filing](https://www.sec.gov/Archives/edgar/data/1604665/000160466526000027/0001604665-26-000027-index.htm)
- 8-K · filed 2026-08-04 · 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1604665/000160466526000022/0001604665-26-000022-index.htm)
- 10-Q · filed 2026-05-06 · [filing](https://www.sec.gov/Archives/edgar/data/1604665/000160466526000017/0001604665-26-000017-index.htm)
- 8-K · filed 2026-05-05 · 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1604665/000160466526000013/0001604665-26-000013-index.htm)
- 8-K · filed 2026-04-20 · 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1604665/000119312526164239/0001193125-26-164239-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001604665.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1604665

## Cite

POPS4, Edgar & Edgarette: Westlake Chemical Partners LP (WLKP) company card, from the company's own SEC filings, accessed 2026-11-02, https://www.pops4.com/boards/company/WLKP. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.